← Back to Search

Vascular Embolization

Embolization for Osteoarthritis

University of Minnesota, Minneapolis, MN
Targeting 4 different conditionsGeniculate Artery EmbolizationN/ARecruitingLed by Jafar Golzarian, MDResearch Sponsored by University of Minnesota

Study Summary

This trial is testing a new way to treat osteoarthritis that doesn't involve surgery. They will compare it to the standard of care to see if it is better.

Eligible Conditions
  • Osteoarthritis of the Knee
  • Arthritis
  • Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety as Assessed by Grade 3-4 Adverse events
Secondary outcome measures
C-Reactive Protein Concentration
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS)
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
+5 more
Other outcome measures
Feasibility as Assessed by Protocol Adherence
Feasibility as Assessed by Recruitment Rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GAE + Standard of CareExperimental Treatment1 Intervention
Participants in this arm will receive geniculate artery embolization and standard of care.
Group II: Standard of CareActive Control1 Intervention
Participants in this arm will receive standard of care only.
First Studied
Drug Approval Stage
How many patients have taken this drug
Geniculate Artery Embolization

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,341 Previous Clinical Trials
1,582,447 Total Patients Enrolled
4 Trials studying Osteoarthritis
180 Patients Enrolled for Osteoarthritis
Jafar Golzarian, MDPrincipal InvestigatorUniversity of Minnesota
3 Previous Clinical Trials
379 Total Patients Enrolled
Reza Talaie, MDPrincipal InvestigatorUniversity of Minnesota

Media Library

Geniculate Artery Embolization (Vascular Embolization) Clinical Trial Eligibility Overview. Trial Name: NCT04456569 — N/A
Osteoarthritis Research Study Groups: GAE + Standard of Care, Standard of Care
Osteoarthritis Clinical Trial 2023: Geniculate Artery Embolization Highlights & Side Effects. Trial Name: NCT04456569 — N/A
Geniculate Artery Embolization (Vascular Embolization) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04456569 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT04456569 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity for me to partake in this research experiment?

"To be eligible for this medical trial, patient must have between 40 and 70 years old with a diagnosis of knee osteoarthritis. A total of 20 patients are being recruited at this time."

Answered by AI

How many participants are enrolled in the current experiment?

"Affirmative. According to the data on clinicaltrials.gov, this study is currently looking for participants; it was initially published on February 1st 2022 and had its latest update on September 8th of that same year. The trial requires 20 subjects from a single site."

Answered by AI

Is enrollment open for this experiment at present?

"Correct. According to the clinicaltrials.gov database, this clinical trial is open for enrollment and was first posted on February 1st 2022 with its last update coming on September 8th of that same year. The investigators are now looking for 20 participants from one single site."

Answered by AI

Are elderly patients eligible to participate in this trial?

"Individuals that are eligible for this medical experiment must be between 40 and 70 years old. There are 85 trials open to those below 18, and 918 available to seniors over 65."

Answered by AI

Who else is applying?

What state do they live in?
What site did they apply to?
University of Minnesota
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?

Why did patients apply to this trial?

Pain meds don't help my knee pain, steroid infectio.
PatientReceived 2+ prior treatments

How responsive is this trial?

Average response time
  • < 2 Days
Typically responds via
Most responsive sites:
  1. University of Minnesota: < 48 hours
~2 spots leftby Feb 2024